Command Palette

Search for a command to run...

Clinical Trials · NCT05111912

Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

CompletedPhase 2Liraglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Sciwind Biosciences APAC CO Pty. Ltd.
Enrollment
206
Start date
Nov 2021
Locations
1 site, Australia
Primary endpoint
Percentage change in participants body weight (%) from the Baseline
View Liraglutide compound reference